XOMA
HEALTHCAREXOMA Royalty Corporation
AI Insight
What's Moving XOMA Today?
No stock-specific AI insight has been generated for XOMA yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$22.29$42.81
$42.02
Fundamentals
Market Cap$742M
P/E Ratio26.7
EPS$1.57
Dividend Yield—
Dividend / Share—
ROE34.2%
Profit Margin69.6%
Debt / Equity—
Trading
Volume35K
Avg Volume (10D)—
Shares Outstanding17.7M
XOMA News
25 articles- XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record DateYahoo Finance·Jun 12, 2026
- Oncobiologics, Inc. (OTLK) Reports Q2 Loss, Lags Revenue EstimatesYahoo Finance·May 15, 2026
- Kyntra Bio (KYNB) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·May 11, 2026
- CG Oncology, Inc. (CGON) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·May 8, 2026
- Entrada Therapeutics, Inc. (TRDA) Reports Q1 Loss, Misses Revenue EstimatesYahoo Finance·May 7, 2026
- Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 6, 2026
- XOMA Investors Have the Opportunity to Join Investigation of XOMA Royalty Corporation with the Schall Law FirmGlobeNewswire Inc.·Apr 28, 2026
- XOMA Royalty (XOMA) Moves 10.7% Higher: Will This Strength Last?Yahoo Finance·Apr 28, 2026
- Halper Sadeh LLC is Investigating Whether OGN, XOMA, RMAX, SLNO are Obtaining Fair Deals for their ShareholdersGlobeNewswire Inc.·Apr 28, 2026
- Royalty Powerhouse: Ligand And Xoma Unite In $739 Million DealYahoo Finance·Apr 27, 2026
- Ligand Bets On Royalty Growth With XOMA Buyout Worth Over $700 MillionBenzinga·Apr 27, 2026
- $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of XOMA Royalty Corporation (NASDAQ: XOMA)GlobeNewswire Inc.·Apr 27, 2026
- $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Miluna Acquisition Corp. (NASDAQ: MMTX)GlobeNewswire Inc.·Apr 27, 2026
- Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty AggregatorYahoo Finance·Apr 27, 2026
- We Believe XOMA Royalty's (NASDAQ:XOMA) Earnings Are A Poor Guide For Its ProfitabilityYahoo Finance·Mar 26, 2026
- XOMA Royalty Q4 Earnings Call HighlightsMarketbeat·Mar 18, 2026
- XOMA Royalty Declares Quarterly Preferred Stock DividendsYahoo Finance·Mar 18, 2026
- XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business AchievementsYahoo Finance·Mar 18, 2026
- XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026Yahoo Finance·Mar 12, 2026
- XOMA Royalty to Present at Investor Conferences in MarchYahoo Finance·Feb 18, 2026
- XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.Yahoo Finance·Feb 9, 2026
- Institutional owners may take dramatic actions as XOMA Royalty Corporation's (NASDAQ:XOMA) recent 12% drop adds to one-year lossesYahoo Finance·Jan 18, 2026
- XOMA Royalty Announces CFO TransitionYahoo Finance·Jan 12, 2026
- Implied Volatility Surging for XOMA Royalty Stock OptionsYahoo Finance·Jan 5, 2026
- XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for MezagitamabYahoo Finance·Dec 30, 2025
All 25 articles loaded
Price Data
Open$41.81
Previous Close$41.95
Day High$42.14
Day Low$41.81
52 Week High$42.81
52 Week Low$22.29
52-Week Range
$22.29$42.81
$42.02
Fundamentals
Market Cap$742M
P/E Ratio26.7
EPS$1.57
Dividend Yield—
Dividend / Share—
ROE34.2%
Profit Margin69.6%
Debt / Equity—
Trading
Volume35K
Avg Volume (10D)—
Shares Outstanding17.7M
About XOMA Royalty Corporation
XOMA Corporation, a biotech royalty aggregator, discovers and develops therapeutic candidates in the United States, Europe, and Asia Pacific. The company is headquartered in Emeryville, California.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—